Award

Identification of Metabolomic Profiles for Sarcopenia Traits in Older Whites and Blacks

Description: Sarcopenia, characterized as the age-related loss of muscle mass and function, is a major risk factor for falls, fractures, loss of independence, poor life quality, and mortality among the elderly. To meet the urgent need for effective prediction, diagnosis, and intervention methods for sarcopenia, we propose using the cutting- edge metabolomics approach (a high-throughput method for testing metabolites in biofluids) to systematically discover novel metabolic pathways for the pathogenesis of sarcopenia. The study findings will significantly contribute to our understanding of the biological mechanisms of sarcopenia and developing powerful tools for prediction, diagnosis, and treatment of the disorder.
Funding type: research
Funder scheme: R01
Start date: 2019-09-01
End date: 2025-04-30
Investigator: HUI SHEN (lead)
Institutions: University of Tennessee Health Science Center, UNIVERSITY OF TENNESSEE HEALTH SCI CTR
Field: Medicine
Funded outputs count: 104
Funder award ID: R01AG061917
OpenAlex ID: G3558902290
2026 · Zhuoyuan A. Li, Webb A. Smith, et al. · Frontiers in Pediatrics
2026 · Huang, Lei, Qiu, Chuan, et al. · PubMed Central · 2
2026 · Wanheng Zhang, Chuan Qiu, et al. · Genome Medicine · 1
2026 · Chuan Qiu, Boluwatife L Afolabi, et al. · JBMR Plus · 2
2025 · Lei Huang, Kuan-Jui Su, et al. · Research Square · 2
2025 · Dan‐Yang Liu, Hui Shen, et al. · Clinical Pharmacology & Therapeutics · 6
2025 · Xiaoyu Zhang, Kuan-Jui Su, et al. · Genome biology · 4
2025 · Md Selim Reza, Chuan Qiu, et al. · Journal of Cachexia Sarcopenia and Muscle · 13
2025 · Weiqiang Lin, Yisu Li, et al. · Nucleic Acids Research · 57
2025 · Adit Tal, Shimara Gunawardana-Zeigler, et al. · Molecular Cancer Therapeutics · 8
2025 · Yun Gong, Mohammad Haeri, et al. · Nature Communications · 60